Crispr Therapeutics Ag (CRSP)

01:25 AM

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga

01:25 AM

Jul 25, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Lowered to $78.00 at Bank of America - MarketBeat

Jul 25, 2025

Jul 25, 2025

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Jul 25, 2025

Jul 25, 2025

What drives CRISPR Therapeutics AG stock priceExceptional stock performance - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Private Advisor Group LLC Buys 23,382 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 25, 2025

Jul 25, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Jul 25, 2025

Jul 25, 2025

CRISPR Therapeutics AG Stock Analysis and ForecastExplosive portfolio gains - Autocar Professional

Jul 25, 2025

Jul 24, 2025

Is CRISPR Therapeutics AG a good long term investmentFree Buy/Sell Signal Notifications - Autocar Professional

Jul 24, 2025

Jul 24, 2025

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Jul 24, 2025

Jul 24, 2025

[Latest] Global CRISPR Gene Editing Market Size/Share Worth - GlobeNewswire

Jul 24, 2025

Jul 24, 2025

[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance

Jul 24, 2025

Jul 23, 2025

CRISPR Therapeutics Bets On Gene Editing’s Future With Casgevy - Finimize

Jul 23, 2025

Jul 23, 2025

CRISPR Therapeutics (CRSP) Surges 71% Last Quarter With Inclusion In Russell Indices - simplywall.st

Jul 23, 2025

Jul 23, 2025

Crispr Therapeutics: Shares Are SoaringThis Could Be The Start Of Something Big (CRSP) - Seeking Alpha

Jul 23, 2025

Jul 23, 2025

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN

Jul 23, 2025

Jul 22, 2025

What analysts say about CRISPR Therapeutics AG stockTremendous gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Research Analysts Set Expectations for CRSP Q2 Earnings - MarketBeat

Jul 22, 2025

Jul 22, 2025

Crispr Therapeutics price target lowered to $78 from $79 at BofA - TipRanks

Jul 22, 2025

Jul 21, 2025

CRISPR Therapeutics' Stock Surge: A Glimpse into the Future of Gene-Editing Investment - AInvest

Jul 21, 2025

Jul 21, 2025

CRISPR Therapeutics Rises Amid Gene Editing Breakthroughs - StocksToTrade

Jul 21, 2025

Jul 21, 2025

CRISPR Stock (CRSP) Continues to Sizzle on Insider Deal - TipRanks

Jul 21, 2025

Jul 21, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 1-Year High Following Insider Buying Activity - MarketBeat

Jul 21, 2025

Jul 21, 2025

3 Monster Stocks in the Making to Buy Right Now - The Motley Fool

Jul 21, 2025

Jul 20, 2025

CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading - MSN

Jul 20, 2025

Jul 19, 2025

Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat

Jul 19, 2025

Jul 19, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Average Price Target from Analysts - MarketBeat

Jul 19, 2025

Jul 19, 2025

Crispr Therapeutics AG Stock Soars Amid Insider Confidence - TipRanks

Jul 19, 2025

Jul 19, 2025

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN

Jul 19, 2025